Article
Epigenetic biomarkers in urological tumors: A systematic review.
Cancer letters - 28 Jan 2014
Jerónimo Carmen, Henrique Rui
Abstract excerpt
Prostate, bladder, kidney and testis cancers, the most common genitourinary (GU) neoplasms, are generally clinically silent at their earliest stages when curative treatment is most likely successful. However, there are no consensual guidelines for GU cancer screening and available methods are characterized by suboptimal sensitivity and specificity. Moreover, standard clinical and pathological parameters meet with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
